HANGZHOU, ZHEJIANG, CHINA, January 16, 2026 /EINPresswire.com/ -- The pharmaceutical industry is undergoing a period of ...

HANGZHOU CITY, ZHEJIANG PROVINCE, CHINA, January 20, 2026 /EINPresswire.com/ -- The global fine chemicals industry is ...

JINYE ROAD NO.32, HIGH-TECH ZONE, XI'AN, SHAANXI PROVINCE, CHINA, January 16, 2026 /EINPresswire.com/ -- The global ...

Lonza Group stock is a top CDMO benefiting from biopharma outsourcing, strong growth, and expanding margins. Learn more about ...

TOKYO, JAPAN, January 14, 2026 / EINPresswire.com / — LOTTE Holdings, Co., Ltd. (Tokyo, Japan; CEO: Genichi Tamatsuka, ...

Microsize brings over thirty years of expertise in specialized particle size engineering for the pharmaceutical industry, ...

The drugmaker's full-year results didn't seem to move the needle for investors who are instead focused on future growth ...

The Phase 1 clinical study is expected to enroll approximately 24 healthy adult volunteers. The primary objectives of the study are to characterize the pharmacokinetic release profile of the nalmefene ...

Pfizer has spent billions of dollars on acquisitions in the past few decades. Its biggest deals include Warner-Lambert, ...

Through Nov. 15 of last year, pharma deal value rose 79% compared to the same period in 2024, according to Bain. The average deal size also climbed more than 80%, “signaling a decisive return of ...

The Swiss drug services firm Siegfried plans to acquire two small-molecule manufacturing sites in the US and one in Australia ...

As of Wednesday, January 28, Lexicon Pharmaceuticals, Inc.’s LXRX share price has dipped by 7.60%, which has investors ...